[{"id":"156f87f7-921b-4a1f-a91b-1eae21e8d897","acronym":"","url":"https://clinicaltrials.gov/study/NCT04840875","created_at":"2021-04-12T15:52:30.119Z","updated_at":"2024-07-02T16:36:05.508Z","phase":"Phase 1","brief_title":"Phase I Clinical Trial of Autologous CD7-CAR T Cells in the Treatment of High-risk Acute T-cell Leukemia / Lymphoma","source_id_and_acronym":"NCT04840875","lead_sponsor":"Beijing Boren Hospital","biomarkers":" CD7","pipe":"","alterations":" ","tags":["CD7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • autologous CD7-CAR T cells"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 04/20/2021","start_date":" 04/20/2021","primary_txt":" Primary completion: 04/20/2023","primary_completion_date":" 04/20/2023","study_txt":" Completion: 04/20/2025","study_completion_date":" 04/20/2025","last_update_posted":"2022-08-15"}]